Table 1.
Drug | Action: indication | Daily dose: standard | Characteristics |
---|---|---|---|
Allopurinol orally | XOi: all | 100–900 mg: 300 mg | Dosage adjustment to renal function |
Benzbromarone orally | Urate transporter: low excretor, subject to intolerance or allergy to allopurinol | 50–200 mg: 100 mg | Poor efficacy in severe renal function impairment |
Febuxostat orally | XOi: all, particularly in Allo intolerance | 40–120 mg: 80 mg | No dosage adjustment in renal impairment |
Probenecid orally | Urate transporter: low excretor | 500–2,000 mg: 1,000 mg | Poor efficacy in moderate to severe renal function |
Rasburicase iv | UrO: lytic effect on tophi | Compassionate use: eg, 0.2 mg/kg in 60 min; infusion on d 1, then 1x per wk; (+methylprednisolone 100 mg iv) | Biological |
Pegloticase iv | UrO: chronic refractory gout | 8 mg every 2–4 wk | Biological |
Abbreviations: XOi, xanthine oxidase inhibitor; iv, intravenous; UrO, urate oxidase.